Right ventricular outflow tract obstruction risk factors

Right ventricular outflow tract obstruction Microchapters
Home
Patient Information
Overview
Anatomy of Pulmonary Valve
Classification
Pulmonary valve stenosis
Pulmonary subvalvular stenosis
Pulmonary supravalvular stenosis
Pulmonary atresia
Pathophysiology
Causes
Differentiating Right ventricular outflow tract obstruction from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac Catheterization
Pulmonary Angiography
Treatment
Indications For Surgery
Surgery
Pre-Operative A/P
Post-Operative A/P
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pulmonary artery conduits/Prosthetic Valves
Double-Chambered Right Ventricle
Case Studies
Case #1
Right ventricular outflow tract obstruction risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Right ventricular outflow tract obstruction risk factors
CDC on Right ventricular outflow tract obstruction risk factors
Right ventricular outflow tract obstruction risk factors in the news
Blogs on Right ventricular outflow tract obstruction risk factors
Directions to Hospitals Treating Right ventricular outflow tract obstruction risk factors
Risk calculators and risk factors for Right ventricular outflow tract obstruction risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including pulmonic stenosis.

References

Template:WikiDoc Sources